Mayo Clinic Pharmacy Grand Rounds

Statin Intolerance and Clear Alternatives

Andrea Aguayo, PharmD provides insights on statin intolerance and alternative approaches.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Nirsevimab: Prevent RSV or Let it Be?

Kimberly James, PharmD shares developments on respiratory syncytial virus (RSV) prevention in infants.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Starting off STRONG: Optimizing Heart Failure Treatment at Transitions of Care

Krysta Larson, PharmD provides updates on heart failure treatment strategies in transitions of care.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

When Drugs BITE Back: Managing Toxicities of Bispecific T-Cell Engagers

Jenna Puttkamer, PharmD shares insights into toxicity management of bispecific t-cell engagers.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Colchi(seen) to Reduce Cardiovascular Risk in Established ASCVD

Maggie Ruschmeyer, PharmD reviews the evidence in colchicine for secondary prevention of ASCVD.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

It’s Not All Negative: Antibody Drug Conjugates in HER-2 Low Breast Cancer

Brianna Chambers, PharmD describes the landscape for HER-2 low classification in the treatment of breast cancer.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

The Intensive Approach: Updates for Blood Pressure Control in Intracerebral Hemorrhage

Allie Curran, PharmD reviews blood pressure management strategies in intracerebral hemorrhage.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

My, Oh, Myocarditis: More to Monitor for Clozapine?

Caitlin Schanz, PharmD discusses considerations for clozapine-induced myocarditis.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Going Viral! Reactivation of Viral Infections Following Cancer Treatment

Abdullah Al-Ajmi, PharmD, BCPS reviews approaches to viral reactivation following cancer treatment.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Don’t Lose Your Nerve: Supporting the Denervated Heart after Cardiac Transplantation

Tanner Melton, PharmD reviews pharmacologic management of post cardiac transplant.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.